Valuation Genmab A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 13/01/2026 GMT			5-day change	1st Jan Change
2,146.00 ^DKK	-0.74%		+6.77%	+5.87%

01-08	UBS Raises Price Target for Genmab to 2,750 Danish Kroner (from 2,700), Reiterates Buy	FW
01-07	Genmab A/S Partners with Anthropic to Accelerate Research and Development Through Agentic Artificial Intelligence	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	161,105	172,063	192,229	140,770	94,810	132,192	132,192	-
Change	-	6.8%	11.72%	-26.77%	-32.65%	39.43%	0%	-
Enterprise Value (EV) ¹	145,026	152,725	169,905	112,635	73,709	110,226	101,473	91,961
Change	-	5.31%	11.25%	-33.71%	-34.56%	49.54%	-7.94%	-9.37%
P/E ratio	34.1x	57.8x	35.2x	32.6x	12.3x	18.3x	21.8x	16.3x
PBR	8.5x	7.82x	7.07x	4.5x	2.68x	3.46x	2.98x	2.56x
PEG	-	-1.6x	0.4x	-1.5x	0.1x	-5.71x	-1.3x	0.5x
Capitalization / Revenue	15.9x	20.3x	13.2x	8.54x	4.4x	5.57x	4.82x	4.15x
EV / Revenue	14.3x	18x	11.6x	6.84x	3.42x	4.65x	3.7x	2.89x
EV / EBITDA	22.1x	46.8x	25.3x	20.1x	10.4x	12.2x	10.5x	7.22x
EV / EBIT	23x	50.6x	26.7x	21.2x	10.5x	13.1x	11.5x	8.07x
EV / FCF	23.7x	77.3x	47.3x	16.1x	9.72x	18x	11.4x	8.17x
FCF Yield	4.22%	1.29%	2.12%	6.23%	10.3%	5.55%	8.77%	12.2%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	72.21	45.54	83.65	66.02	121.4	117.5	98.26	132
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	10,111	8,482	14,595	16,474	21,526	23,713	27,405	31,869
EBITDA ¹	6,572	3,266	6,719	5,616	7,116	9,048	9,637	12,740
EBIT ¹	6,313	3,018	6,357	5,321	7,003	8,422	8,803	11,401
Net income ¹	4,758	3,008	5,522	4,352	7,844	7,457	6,406	9,438
Net Debt ¹	-16,079	-19,338	-22,324	-28,135	-21,101	-21,966	-30,719	-40,231
Reference price ²	2,463.00	2,630.00	2,941.00	2,155.00	1,492.50	2,146.00	2,146.00	2,146.00
Nbr of stocks (in thousands)	65,410	65,423	65,362	65,322	63,524	61,599	61,599	-
Announcement Date	23/02/21	16/02/22	22/02/23	14/02/24	12/02/25	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GENMAB A/S	18.4x	4.69x	12.29x	-.--%	20.81B
ARGENX SE	44.66x	10.63x	38.02x	0.02%	48.01B
WUXI APPTEC CO., LTD.	17.33x	6.12x	13.66x	1.66%	41.97B
INSMED INCORPORATED	-27.95x	64.09x	-31.24x	-.--%	35.77B
BIONTECH SE	-25.81x	4.22x	-11.51x	-.--%	25.64B
WUXI BIOLOGICS (CAYMAN) INC.	31.13x	6.14x	17.01x	-.--%	19.92B
SUMMIT THERAPEUTICS INC.	-13.07x	163.98x	-25.57x	-.--%	13.14B
AKESO, INC.	-510.23x	30x	534.65x	-.--%	14.9B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-212.66x	50.74x	-205.58x	-.--%	14.63B
EXELIXIS, INC.	17.03x	4.86x	11.99x	-.--%	11.86B
Average	-66.12x	34.55x	35.37x	0.17%	24.67B
Weighted average by Cap.	-34.33x	27.52x	25.73x	0.29%